Health Care: Drugs

Bioline Rx Ltd. (BLRX: NASDAQ)

$1.64 0.00 | 0.00%

06/18/13 - 03:58 PM ET

Growth Rates

Portfolios with BLRX

Portfolio NameUser Type
Contributor
Stocks Under-$10 Setting Up...
Contributor
Stocks Under-$10 Moving Hig...

Latest BLRX Headlines from TheStreet

5 Stocks Under $10 Set to Soar
04.18.13 | 02:04 pm
BioLineRx Shares Fall On Schizophrenia Drug Failure
03.20.13 | 10:03 am
4 Stocks Under $5 Making Big Moves
02.22.13 | 03:02 pm
BioLineRx: Tuesday's Hot Hep C Drug Stock
01.24.12 | 11:01 am

More Financial News for BLRX

Press Releases for BLRX

Oramed Pharmaceuticals Appoints New Chief Operating Officer And VP Of Business Development - PR Newswire 04.16.13 | 09:04 am
BioLineRx Announces Results From Interim Analysis Of Phase II/III CLARITY Trial Of BL-1020 For Schizophrenia - Business Wire 03.20.13 | 09:03 am
BioLineRx Receives Approval From French Regulatory Authorities To Commence A Phase I/II Clinical Trial For BL-8020, An Oral, Interferon-Free Treatment For Hepatitis C - Business Wire 03.13.13 | 07:03 am
BioLineRx Reports Year End 2012 Financial Results - Business Wire 03.12.13 | 07:03 am
BioLineRx's EDP-14, For Treatment Of Severe And Persistent Asthma, To Enter The Company's Main Therapeutic Pipeline As BL-9010 - Business Wire 02.28.13 | 07:02 am
BioLineRx To Report Fourth Quarter And Year End 2012 Results On March 12, 2013 - Business Wire 02.26.13 | 07:02 am
BioLineRx Announces Closing Of $8 Million Offering Of American Depositary Shares - Business Wire 02.13.13 | 07:02 am
BioLineRx Announces Offering Of American Depositary Shares - Business Wire 02.06.13 | 09:02 am
BioLineRx Provides Clarification Regarding Interim Analysis Of CLARITY Trial For BL-1020 - Business Wire 02.04.13 | 07:02 am
BioLineRx To Present At The 2013 BIO CEO & Investor Conference In New York On February 12th - Business Wire 01.31.13 | 07:01 am

See All Press Releases

Partner Headlines for BLRX

Morning Market Movers - Benzinga 10.03.12 | 09:10 am
Healthcare Business Review: Vivus DISSED By Citron, Lundbeck, et al Have OPPORTUNITY - Wall St. Cheat Sheet 07.20.12 | 08:07 am
Traders are Up and Actively Waving Hands for These 5 Stocks Today - Wall St. Cheat Sheet 06.05.12 | 01:06 pm
Ultimate Market Recap: GM China Sales Soar, Apple Makes New Macs - Wall St. Cheat Sheet 06.05.12 | 09:06 am
5 High-Risk, High-Reward Biopharma Stocks - Seeking Alpha 02.14.12 | 09:02 am
Company News for January 25, 2012 - Corporate Summary - Zacks 01.25.12 | 10:01 am
Morning Market Movers - Benzinga 09.13.11 | 09:09 am

Refresh Stock Quote for Bioline Rx Ltd. - BLRX

brokerage partners

watch thestreet tv

New Tools Not Inspi...

Lowe's Bids for Orc...

connect with Stockpickr

Fan us on FaceBook

Follow us on Twitter

Home
STOCK GAME
Portfolios

Professional
Stockpickr Spotlight
User Generated
- Recently Updated
Tools

Market Indicators
Upgrades and Downgrades
Daily Lists
Articles
My Stockpickr

GROWTH RATES

REVENUE (Trailing 12 Quarters)